Medical School of Nanjing University, Nanjing, Jiangsu, China.
J Surg Res. 2010 Oct;163(2):e99-104. doi: 10.1016/j.jss.2010.05.030. Epub 2010 Jun 9.
The relationship between elastolytic matrix metalloproteinases (MMPs) (such as MMP-2, MMP-9) and thoracic aortic dissection (TAD) has been described, but little is known regarding the role of collagenolytic MMPs in thoracic aortic dissection. The aim of this study was to determine the role of MMP-8 in acute thoracic aortic dissection.
Forty-five patients affected by TAD and 40 with acute myocardial infarction (AMI) were recruited into this study. Blood samples within 72 h of the onset of symptoms were available for all the 85 patients. Healthy individuals were selected from the out-patients who complained of chest pain but in whom no cardiovascular diseases were found. Plasma levels of MMP-1, -8, -13 were measured by enzyme-linked immunosorbent assay (ELISA) technique in all subjects. Aortic tissue samples obtained during surgery were evaluated by Western blot for MMP-8 and tissue inhibitor of metalloproteinase-1 (TIMP-1) expression.
Plasma MMP-8 levels in patients affected by TAD and AMI were both higher than that in healthy subjects (284.35 ± 96.32 ng/mL and 88.57 ± 26.71 ng/mL versus 75.39 ± 23.36 ng/mL). The difference of the MMP-8 level between TAD patients and healthy subjects was significant (P = 0.000). No significant differences were found in MMP-1 and MMP-13 plasma levels among the three groups.
The acute phase of TAD is characterized by a prominent increase of MMP-8 plasma level, which may play a key role in the occurrence of TAD. MMP-8 could be involved in the acute inflammatory reaction and may be a useful marker for the diagnosis of acute TAD.
弹性蛋白酶基质金属蛋白酶(MMPs)(如 MMP-2、MMP-9)与胸主动脉夹层(TAD)之间的关系已被描述,但对于胶原酶 MMPs 在胸主动脉夹层中的作用知之甚少。本研究旨在确定 MMP-8 在急性胸主动脉夹层中的作用。
招募了 45 例 TAD 患者和 40 例急性心肌梗死(AMI)患者进入本研究。所有 85 例患者均在症状发作后 72 小时内获得血样。健康个体从因胸痛而就诊但未发现心血管疾病的门诊患者中选择。采用酶联免疫吸附试验(ELISA)技术测量所有受试者的 MMP-1、-8、-13 血浆水平。通过 Western blot 评估手术中获得的主动脉组织样本中 MMP-8 和金属蛋白酶组织抑制剂-1(TIMP-1)的表达。
TAD 和 AMI 患者的血浆 MMP-8 水平均高于健康受试者(284.35 ± 96.32 ng/mL 和 88.57 ± 26.71 ng/mL 与 75.39 ± 23.36 ng/mL)。TAD 患者与健康受试者之间的 MMP-8 水平差异有统计学意义(P = 0.000)。三组间 MMP-1 和 MMP-13 的血浆水平无显著差异。
TAD 的急性期表现为 MMP-8 血浆水平的显著升高,这可能在 TAD 的发生中起关键作用。MMP-8 可能参与急性炎症反应,可作为急性 TAD 的诊断有用标志物。